Provided by Tiger Fintech (Singapore) Pte. Ltd.

OPKO Health

1.38
-0.0200-1.43%
Post-market: 1.34-0.0407-2.95%19:55 EDT
Volume:2.58M
Turnover:3.55M
Market Cap:926.74M
PE:-17.99
High:1.40
Open:1.39
Low:1.36
Close:1.40
Loading ...

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

GlobeNewswire
·
28 Feb

Countdown to OPKO Health (OPK) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Zacks
·
25 Feb

Unusually active option classes on open February 24th

TIPRANKS
·
24 Feb

OPKO Health to Announce Q4 2024 Financial Results

TIPRANKS
·
14 Feb

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

GlobeNewswire
·
14 Feb

Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy?

Insider Monkey
·
12 Feb

Insiders continue to buy OPKO Health, Inc. (NASDAQ:OPK) and now own 52% shares

Simply Wall St.
·
06 Feb

OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential

Insider Monkey
·
21 Jan

Opko, BioReference to pay over $700K to resolve False Claims Act allegations

TIPRANKS
·
18 Jan

Top Research Reports for Visa, AbbVie & Analog Devices

Zacks
·
16 Jan

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

Zacks
·
09 Jan

OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains

Zacks
·
08 Jan

OPKO Health Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
08 Jan

OPKO Health's ModeX Launches Phase 1 EBV Vaccine Candidate Trials With Merck

MT Newswires Live
·
08 Jan

BRIEF-OPKO Health’S Modex Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study In Collaboration With Merck

Reuters
·
07 Jan

OPKO Health’s Modex Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration With Merck

THOMSON REUTERS
·
07 Jan

Modex Therapeutics- Development Triggers Undisclosed Milestone Payment From Merck

THOMSON REUTERS
·
07 Jan

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

GlobeNewswire
·
07 Jan

FACTBOX-Weight-loss drug developers line up to tap market worth $150 billion

Reuters
·
20 Dec 2024

Is OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now?

Insider Monkey
·
11 Dec 2024